Direct compression formulation and process

Details for Australian Patent Application No. 2006206670 (hide)

Owner Novartis AG

Inventors Schaefer, Frank; Pfeffer, Sabine; Wirth, Wolfgang; Schneeberger, Ricardo; Trueby, Martin Friedrich; Sutton, Paul Allen

Agent Davies Collison Cave

Pub. Number AU-B-2006206670

PCT Pub. Number WO2006/078593

Priority 60/644,645 18.01.05 US; 60/690,484 14.06.05 US

Filing date 17 January 2006

Wipo publication date 27 July 2006

Acceptance publication date 15 April 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/195 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/078593 Priority application(s): WO2006/078593

15 April 2010 Application Accepted

  Published as AU-B-2006206670

12 August 2010 Standard Patent Sealed

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206675-Mitotic kinesin inhibitors

2006206666-Power management in operating recording media